Johnson & Johnson to Acquire Intra-Cellular Therapies for $14.6 Billion, Strengthening Mental Health Portfolio
Johnson & Johnson (J&J) announced Monday that it will acquire Intra-Cellular Therapies, a company specializing in mental health treatments, in ...